Our next symposium will be on Tuesday 26th November 2019. Programme can be found here.
Thank you to everyone who attended our summer symposium!
Welcome to the PDIG section of the GHP website.
Our Autumn Symposium programme is now available here.
Latest posts for PDIG
- Procurement & Distribution Interest Group Autumn Symposium
- Archive of PDIG Presentations
- PDIG Autumn Symposium Thu 8th Nov 2018
- PDIG Summer Symposium: Application Form
- PDIG 2017 Presentations
- PDIG Autumn Symposium– Thursday 2nd November 2017
- PDIG Presentations available to download
- Summer Symposium Programme – Wednesday 21st June 2017
- PDIG Information Page
GHP Procurement & Distribution Interest Group (PDIG)
We are delighted to open applications for our Autumn Symposium. The details are…
Thursday 2nd November 2007,
Hilton Birmingham Metropole Hotel, National Exhibition Centre, B40 1PP
Please send all application forms and conference queries to Noeline Johnston.
E-mail address: email@example.com
Tel: 028 90232381 (switchboard) or 028 90029412 (direct dial)
Programme. More details here…PDIG June 2017
The presentations from the summer symposium are now available here…
|9.00am||Arrival, Registration, Coffee & Tea|
|10.00am||Chairman’s Welcome & Introduction||Margaret Dolan, Chair, PDIG|
|10.10am|| NHS Medicines Contracting – The Future!
§ What contracting process will be used and what will be the impact upon existing structures and systems?
§ What are the challenges and opportunities?
§ How will the NHS and Pharmaceutical Industry work in partnership?
National Commercial Director,
|10.50am||Specialist Pharmacy Services (SPS) and the National Standardisation programme
§ What is the role of SPS?
§ What is the plan for a Catalogue of NHS-made medicines?
§ What else is on the workplan for NHS-made medicines?
| Tim Root
Clinical Governance & Technical Services,
NHS Specialist Pharmacy Service
|12.00noon||Cancer Medicines – The Transformation
§ How has the funding and evaluation of cancer drugs changed?
§ How will biosimilar monoclonal antibodies be introduced into practice?
§ What are the Cancer Vanguards and how will they impact on cancer treatments?
| David Thomson
Chemotherapy Pharmacist –NHS England
The Royal Marsden NHS Foundation Trust
|2.15pm|| Restricted use of open systems for injectable
medication – background and implications§ Background to development of patient safety alerts
§ Background to the ‘open systems’ alert
§ Implications of the alert for Pharmacy and the pharmaceutical industry
Graeme KirkpatrickHead of Patient Safety (Advice and Guidance) NHS Improvement
|2.45pm|| The challenges of NHS Medicines Procurement and
Distribution? – Industry Views A panel discussion
§ What are the most significant current issues?
§ What plans are in place to address these?
§ How can the NHS assist?
| Dr Rick Greville
Director Wales and Director Distribution &
Healthcare Distribution Association
Director General, BGMA
|Summary and Close||Margaret Dolan, Chair, PDIG|